Analyst Consensus ?
ConsensusBuy27 ratings
Bullish2385.2%
Neutral414.8%
Bearish00.0%
KKR & Co. Inc. · KKR · FY2026 Q3 · Calendar Q4 2026
KKR’s record quarter pairs fee growth with deployment and liquidity
The supplied analysis portrays a strong quarter supported by management-fee growth, fundraising and capital deployment, while the durability of fee growth and execution across insurance and AI infrastructure remain important tests. The reported EPS beat was accompanied by revenue below consensus, so the quarter was not uniformly stronger across headline comparisons.
Why did KKR rise 1.7% after beating EPS estimates in FY2026 Q3?
Research this report with FN2. Free to start; review your question before sending.
Reported Before market openNYSEFinancial Services
$88.05B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.78
Consensus $1.58
EPS surprise
+12.7%
Reported versus consensus
Reported revenue
$2.61B
Consensus $2.66B
Revenue surprise
-1.8%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+1.7%
Event window
SPY move
+2.4%
Same window
Abnormal move
-0.7%
Stock minus SPY
Volume
1.4×
Versus trailing sessions
Subsequent drift
0.0%
Up to 20 sessions
KKRSPY benchmark
Ask FN2 about KKR FY2026 Q3
Choose a question to continue your research
Why did KKR rise 1.7% after beating EPS estimates in FY2026 Q3?What changed in KKR's guidance and outlook in FY2026 Q3?Give me the bull and bear case for KKR after FY2026 Q3 earnings.
Free to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, the current call analysis adds a record dry-powder position, the USI sale proceeds and a planned governance transition to one-share-one-vote. It also describes a proposed GP-led secondary strategy and continued expansion of KKR Solutions and infrastructure offerings.
Guidance delta
Guidance sentiment is described as maintained. The supplied analysis does not specify a new formal numerical guidance range.
Key takeaways
- The transcript analysis characterizes Q3 as a record quarter across headline metrics, with a higher fee-related earnings margin.
- Fundraising and deployment were strong in the supplied analysis, while substantial dry powder positions KKR for future activity.
- The USI divestiture is described as a source of liquidity and potential earnings support; capital allocation priorities include buybacks, strategic holdings and insurance.
- Reported EPS exceeded consensus, while reported revenue was below consensus; results therefore show a mixed comparison against estimates.
Management priorities
- Continue fundraising and capital deployment across infrastructure, private equity and other strategies.
- Build KKR Solutions toward the stated AUM objective and expand GP-solutions offerings.
- Deploy USI sale proceeds across buybacks, strategic holdings, insurance and M&A.
- Advance the governance transition to one-share-one-vote and pursue additional K-Series products and retirement-plan access initiatives.
Follow KKR with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$100.83Current
$63Low
$119.37Average
$190High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 11, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Nov 10, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Nov 10, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Nov 10, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Nov 10, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Nov 10, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Oct 27, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 26, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Oct 19, 2026 |
| UBS | Buy | Buy | Maintain | Oct 13, 2026 |
| TD Cowen | Hold | Hold | Maintain | Oct 12, 2026 |
| Argus Research | Buy | Buy | Maintain | Aug 4, 2026 |
| HSBC | Buy | Buy | Maintain | Jul 20, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 7, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 13, 2025 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Aug 4, 2025 |
| JMP Securities | Market Perform | Market Outperform | Downgrade | Jul 14, 2025 |
| B of A Securities | Buy | Buy | Maintain | Apr 4, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Nov 11, 2024 |
| Jefferies | Buy | Buy | Maintain | May 9, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | May 9, 2023 |
| CFRA | Buy | Hold | Upgrade | May 11, 2020 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | May 7, 2020 |
| Bank of America | Buy | Neutral | Upgrade | Sep 23, 2019 |
| Argus | Buy | Hold | Upgrade | Oct 26, 2018 |
| PiperJaffray | Overweight | Overweight | Maintain | Jun 3, 2015 |
| Evercore Partners | Overweight | Equal Weight | Upgrade | May 13, 2014 |
| Bernstein | Outperform | Outperform | Maintain | Apr 3, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $100.84. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Daniel Welden | $105 | $98.09 | +4.1% | Nov 10, 2026 |
| BMO Capital | Analyst unavailable | $109 | $91.61 | +8.1% | Oct 27, 2026 |
| Barclays | Analyst unavailable | $127 | $91.34 | +25.9% | Oct 26, 2026 |
| Piper Sandler | Analyst unavailable | $121 | $86.21 | +20.0% | Oct 19, 2026 |
| Morgan Stanley | Analyst unavailable | $138 | $89 | +36.9% | Oct 16, 2026 |
| UBS | Analyst unavailable | $122 | $89.14 | +21.0% | Oct 13, 2026 |
| Barclays | Analyst unavailable | $130 | $89.67 | +28.9% | Oct 8, 2026 |
| Wells Fargo | Daniel Welden | $97 | $91.24 | -3.8% | Oct 1, 2026 |
| UBS | Michael Brown | $123 | $106.88 | +22.0% | Sep 1, 2026 |
| Piper Sandler | Crispin Love | $128 | $114.98 | +26.9% | Aug 14, 2026 |
| Deutsche Bank | Brian Bedell | $116 | $102.8 | +15.0% | Aug 3, 2026 |
| BMO Capital | Brennan Hawken | $118 | $101.43 | +17.0% | Aug 3, 2026 |
| RBC Capital | Analyst unavailable | $134 | $100.62 | +32.9% | Jul 31, 2026 |
| Barclays | Benjamin Budish | $135 | $100.98 | +33.9% | Jul 31, 2026 |
| Morgan Stanley | Analyst unavailable | $147 | $97.2 | +45.8% | Jul 21, 2026 |
| HSBC | Analyst unavailable | $121 | $100.94 | +20.0% | Jul 20, 2026 |
| BMO Capital | Brennan Hawken | $112 | $96.8 | +11.1% | Jul 13, 2026 |
| Barclays | Analyst unavailable | $124 | $96.27 | +23.0% | Jul 10, 2026 |
| UBS | Analyst unavailable | $126 | $101.4 | +25.0% | May 6, 2026 |
| Barclays | Analyst unavailable | $122 | $102 | +21.0% | May 6, 2026 |
| Morgan Stanley | Analyst unavailable | $153 | $106.76 | +51.7% | Apr 21, 2026 |
| Evercore ISI | Analyst unavailable | $119 | $106.68 | +18.0% | Apr 21, 2026 |
| RBC Capital | Analyst unavailable | $137 | $92.19 | +35.9% | Feb 23, 2026 |
| UBS | Analyst unavailable | $125 | $102.33 | +24.0% | Feb 20, 2026 |
| Morgan Stanley | Analyst unavailable | $177 | $102.46 | +75.5% | Feb 6, 2026 |
| Evercore ISI | Analyst unavailable | $125 | $102.58 | +24.0% | Feb 6, 2026 |
| Oppenheimer | Chris Kotowski | $187 | $102.04 | +85.5% | Feb 6, 2026 |
| Barclays | Analyst unavailable | $136 | $99.17 | +34.9% | Feb 6, 2026 |
| HSBC | Analyst unavailable | $144 | $116 | +42.8% | Jan 27, 2026 |
| Morgan Stanley | Analyst unavailable | $176 | $118.65 | +74.5% | Jan 27, 2026 |
| Oppenheimer | Analyst unavailable | $190 | $125.76 | +88.4% | Jan 20, 2026 |
| UBS | Analyst unavailable | $168 | $129.61 | +66.6% | Jan 13, 2026 |
| Barclays | Analyst unavailable | $159 | $133.64 | +57.7% | Jan 9, 2026 |
| Barclays | Analyst unavailable | $169 | $142.74 | +67.6% | Dec 12, 2025 |
| UBS | Michael Brown | $176 | $141.54 | +74.5% | Dec 11, 2025 |
| Barclays | Benjamin Budish | $154 | $120.11 | +52.7% | Nov 11, 2025 |
| Barclays | Analyst unavailable | $151 | $118.33 | +49.7% | Nov 3, 2025 |
| Morgan Stanley | Analyst unavailable | $166 | $122.6 | +64.6% | Oct 21, 2025 |
| Piper Sandler | Analyst unavailable | $155 | $124.42 | +53.7% | Oct 7, 2025 |
| Wolfe Research | Steven Chubak | $159 | $143.05 | +57.7% | Jul 10, 2025 |
| HSBC | Vikram Gandhi | $119 | $104.23 | +18.0% | Apr 15, 2025 |
| Wells Fargo | Analyst unavailable | $141 | $116.71 | +39.8% | Mar 20, 2025 |
| Wolfe Research | Steven Chubak | $185 | $150.92 | +83.5% | Jan 3, 2025 |
| JMP Securities | Devin Ryan | $150 | $131.35 | +48.8% | Oct 9, 2024 |
| Goldman Sachs | Alexander Blostein | $137 | $132.6 | +35.9% | Sep 24, 2024 |
| HSBC | Vikram Gandhi | $148 | $127.97 | +46.8% | Sep 18, 2024 |
| Redburn Partners | Nicholas Watts | $153 | $122.15 | +51.7% | Aug 27, 2024 |
| Oppenheimer | Chris Kotowski | $128 | $123.45 | +26.9% | Aug 1, 2024 |
| Evercore ISI | Glenn Schorr | $117 | $110.74 | +16.0% | Jul 15, 2024 |
| Oppenheimer | Chris Kotowski | $121 | $104.98 | +20.0% | Jul 8, 2024 |
| Deutsche Bank | Brian Bedell | $129 | $109.72 | +27.9% | Jun 10, 2024 |
| Jefferies | Daniel Fannon | $113 | $99.67 | +12.1% | May 9, 2024 |
| Deutsche Bank | Brian Bedell | $120 | $95.12 | +19.0% | May 2, 2024 |
| JMP Securities | Devin Ryan | $115 | $95.51 | +14.0% | Apr 15, 2024 |
| Barclays | Benjamin Budish | $113 | $100.93 | +12.1% | Apr 8, 2024 |
| Deutsche Bank | Brian Bedell | $122 | $98.17 | +21.0% | Apr 5, 2024 |
| Oppenheimer | Chris Kotowski | $91 | $61.19 | -9.8% | Aug 8, 2023 |
| Wells Fargo | Analyst unavailable | $65 | $58.94 | -35.5% | Feb 8, 2023 |
| JMP Securities | Analyst unavailable | $72 | $49.64 | -28.6% | Jan 10, 2023 |
| Deutsche Bank | Analyst unavailable | $65 | $54.71 | -35.5% | Nov 15, 2022 |
| Deutsche Bank | Analyst unavailable | $68 | $56.79 | -32.6% | Aug 12, 2022 |
| Morgan Stanley | Analyst unavailable | $60 | $50.4 | -40.5% | Jul 19, 2022 |
| Deutsche Bank | Analyst unavailable | $66 | $46.17 | -34.5% | Jul 13, 2022 |
| Wells Fargo | Analyst unavailable | $63 | $45.53 | -37.5% | Jul 13, 2022 |
| JMP Securities | Analyst unavailable | $80 | $47.72 | -20.7% | Jul 12, 2022 |
| Piper Sandler | Analyst unavailable | $80 | $47.55 | -20.7% | Jul 11, 2022 |
| Goldman Sachs | Analyst unavailable | $63 | $47.35 | -37.5% | Jun 29, 2022 |
| Deutsche Bank | Brian Bedell | $79 | $50.46 | -21.7% | May 19, 2022 |
| Morgan Stanley | Analyst unavailable | $72 | $50.93 | -28.6% | May 10, 2022 |
| Wells Fargo | Analyst unavailable | $72 | $54.44 | -28.6% | May 4, 2022 |
| Morgan Stanley | Analyst unavailable | $71 | $58.18 | -29.6% | Apr 20, 2022 |
| Wells Fargo | Analyst unavailable | $73 | $56.13 | -27.6% | Apr 19, 2022 |
| Citigroup | William Katz | $81.5 | $55.25 | -19.2% | Apr 16, 2022 |
| Piper Sandler | Sumeet Mody | $91 | $80.74 | -9.8% | Nov 4, 2021 |
| BMO Capital | James Fotheringham | $83 | $65.61 | -17.7% | Aug 4, 2021 |
| Barclays | Jeremy Campbell | $63 | $57.59 | -37.5% | May 5, 2021 |
Track every rating change on KKR the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationKKR & Co. Inc. is a prominent global investment powerhouse, deeply engaged in both private equity and real estate. The firm's diverse investment strategies encompass direct capital deployment as well as fund-of-funds approaches, specializing in corporate acquisitions, leveraged and management buyouts, growth equity, and a range of special situations including credit, distressed assets, and turnarounds. They also target mature and mezzanine financing opportunities, spanning companies across the lower and middle market segments. While opportunistic across all industries, KKR exhibits a keen focus on technology sectors, including software, cybersecurity, semiconductors, consumer electronics, the Internet of Things (IoT), internet services, IT infrastructure, and FinTech. Their extensive portfolio also encompasses energy, infrastructure, and a broad array of real estate ventures.…
Historical context
All KKR earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| BAP Credicorp Ltd. | FY2026 Q3 · Calendar Q4 2026 | -2.6% | +3.3% | Credicorp maintains 2026 guidance as lending and fee growth meet El Niño risks |
| CIB Grupo Cibest S.A. | FY2026 Q3 · Calendar Q4 2026 | -10.1% | -4.0% | Grupo Cibest raises loan-growth outlook as commercial lending and Nequi underpin Q3 |
| MGRE Affiliated Managers Group, Inc. | FY2026 Q3 · Calendar Q4 2026 | +8.1% | +0.6% | AMG: Alternatives drive record Q3 as firm maintains Q4 outlook |
| MGRD Affiliated Managers Group, Inc. | FY2026 Q3 · Calendar Q4 2026 | +8.1% | +1.4% | AMG’s Q3 Growth Centers on Alternatives, Inflows and Buybacks |
| MGRB Affiliated Managers Group, Inc. | FY2026 Q3 · Calendar Q4 2026 | +8.1% | +1.4% | AMG’s alternatives-led growth strengthens, while revenue misses estimates |
| AMG Affiliated Managers Group, Inc. | FY2026 Q3 · Calendar Q4 2026 | +8.1% | +5.6% | AMG posts record Q3, with alternatives driving inflows and earnings |
Latest beats and misses
Who reports nextBeat on EPS
- VGFY2026 Q3 · November 10, 2026+92.7% EPS+1.7% move
- TDGFY2026 Q4 · November 10, 2026+1.9% EPS+0.5% move
- ONONFY2026 Q3 · November 10, 2026+39.9% EPS-7.5% move
- CRWVFY2026 Q3 · November 10, 20260.0% EPS-0.5% move
- OXYFY2026 Q3 · November 9, 2026+30.8% EPS+2.0% move
- MGREFY2026 Q3 · November 9, 2026+8.1% EPS+0.6% move
Missed on EPS
- EMBJFY2026 Q3 · November 10, 2026-49.4% EPS+7.0% move
- VODFY2027 Q2 · November 10, 2026-72.8% EPS-1.2% move
- SEFY2026 Q3 · November 10, 2026-5.1% EPS-1.5% move
- BAPFY2026 Q3 · November 9, 2026-2.6% EPS+3.3% move
- JBSFY2026 Q3 · November 9, 2026-28.6% EPS-5.5% move
- CIBFY2026 Q3 · November 9, 2026-10.1% EPS-4.0% move
Get the KKR recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-11-09T22:07:06.376699+00:00
- FN2 earnings calendar · 2026-11-10T01:23:14.443147+00:00
- Polygon adjusted daily market bars · 2026-11-10T10:40:45.439150+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-10T10:40:45.436368+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-10. For educational purposes only; not investment advice.